Literature DB >> 20424287

Ten reasons to be happy about hormone replacement therapy: a guide for patients.

John Studd1.   

Abstract

In spite of the negative press reports following the 2002 Women's Health Initiative (WHI) publication, women can be reassured that in the correct circumstances, hormone replacement therapy (HRT) is beneficial and safe, particularly if treatment is started below the age of 60. Transdermal estradiol is probably safer than oral estrogens as coagulation factors are not induced in the liver and HRT is safer if a minimal duration and dose of progestogen is used. HRT is effective for the treatment of estrogen-deficiency symptoms of flushes, sweats and vaginal dryness. Estrogens prevent osteoporotic fractures and should be first-choice therapy, rather than bisphosphonates. Similarly, HRT protects the intervertebral discs in a way that non-hormonal preparations do not. Estrogens perhaps with the addition of testosterone help certain sorts of reproductive depression, as well as improving energy and libido. There is new evidence to support the previous observational studies that HRT reduces the incidence of heart attacks. Estrogen therapy has a beneficial effect upon collagen, thus improving the texture of the skin, the nails, the intervertebral discs and bone matrix. Discussion of side-effects should not be avoided, particularly the 1% extra lifetime risk of breast cancer. This should be balanced against the fewer heart attacks, fewer deaths and less osteoporotic fractures in those who start HRT below the age of 60.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20424287     DOI: 10.1258/mi.2010.010001

Source DB:  PubMed          Journal:  Menopause Int        ISSN: 1754-0453


  5 in total

1.  MPA: medroxy-progesterone acetate contributes to much poor advice for women.

Authors:  Cynthia L Bethea
Journal:  Endocrinology       Date:  2011-02       Impact factor: 4.736

2.  Research resource: Aorta- and liver-specific ERα-binding patterns and gene regulation by estrogen.

Authors:  Francesca K Gordon; Caroline S Vallaster; Thomas Westerling; Lakshmanan K Iyer; Myles Brown; Gavin R Schnitzler
Journal:  Mol Endocrinol       Date:  2014-07-03

3.  Beta-estradiol attenuates hypoxic pulmonary hypertension by stabilizing the expression of p27kip1 in rats.

Authors:  Dun-Quan Xu; Ying Luo; Yi Liu; Jing Wang; Bo Zhang; Min Xu; Yan-Xia Wang; Hai-Ying Dong; Ming-Qing Dong; Peng-Tao Zhao; Wen Niu; Man-Ling Liu; Yu-Qi Gao; Zhi-Chao Li
Journal:  Respir Res       Date:  2010-12-24

4.  Can depression be a menopause-associated risk?

Authors:  Claudio N Soares
Journal:  BMC Med       Date:  2010-12-01       Impact factor: 8.775

5.  ER Alpha Rapid Signaling Is Required for Estrogen Induced Proliferation and Migration of Vascular Endothelial Cells.

Authors:  Qing Lu; Gavin R Schnitzler; Kazutaka Ueda; Lakshmanan K Iyer; Olga I Diomede; Tiffany Andrade; Richard H Karas
Journal:  PLoS One       Date:  2016-04-01       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.